Challenges and innovations in the surgical treatment of advanced Dupuytren disease by percutaneous needle fasciotomy: indications, limitations, and medico-legal implications | Journal of Orthopaedic Surgery and Research
admin
Eaton C. Percutaneous fasciotomy for Dupuytren contracture. J Hand Surg Am. 2011;36(5):910–5. https://doi.org/10.1016/j.jhsa.2011.02.016
Gil JA, Akelman MR, Hresko AM, Akelman E. Current concepts in the management of Dupuytren disease of the hand. J Am Acad Orthop Surg. 202;29:462–9. https://doi.org/10.5435/JAAOS-D-20-00190
Pagnotta A. Epidemiologia ed eziopatogenesi della malattia di Dupuytren. Riv Chir Mano. 2011;48:100–3.
Kondrup F, Gaudreault N, Venne G. The deep fascia and its role in chronic pain and pathological conditions: a review. Clin Anat. 2022;35:649–59. https://doi.org/10.1002/ca.23882
Cheng HS, Hung LK, Tse WL. Needle aponeurotomy for Dupuytren’s contracture. J Orthop Surg. 2008;16:88–90. https://doi.org/10.1177/230949900801600120
Descatha A, Bodin J, Ha C, Goubault P, Lebreton M, Chastang JF, et al. Heavy manual work, exposure to vibration and Dupuytren’s disease? Results of a surveillance program for musculoskeletal disorders. Occup Environ Med. 2012;69:296–9. https://doi.org/10.1136/oemed-2011-100319
Wiesel SW. Operative techniques in orthopaedic surgery. Second Edition. Wolters Kluwer. 2015 – Chap. 106 Surgical Treatment of Dupuytren Disease. Ghazi Rayan. ISBN 978-0-7817-6370-7.
Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren’s contracture. J Hand Surg. 1998;13(6):254. https://doi.org/10.1016/0266-7681_88_90079-4
Lipman MD, Carstensen SE, Deal DN. Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014. Hand (N Y). 2017;12:13–20. https://doi.org/10.1177/1558944716647101
Hindocha S. Risk factors D, associations, diathesis D. Hand Clin. 2018;34:307–14. https://doi.org/10.1016/j.hcl.2018.03.002
Mella JR, Guo L, Hung V. Dupuytren’s contracture: an evidence based review. Ann Plast Surg. 2018;81:S97-S101. https://doi.org/10.1097/SAP.0000000000001607. PMID: 30161050.
Corte di Cassazione, III sezione civile, sentenza 23 gennaio 2023, n. 1936 – Supreme Court, III civil section, ruling 23 January 2023, n. 1936. Informed Consent violation: the patient’s choice must be ascertained. The Supreme Court upheld the appeal of a health care facility convicted in the Court of Appeals for violation of informed consent for a patient. It held that the Court of Appeals, in order to ascertain the causal relationship between the physician’s misconduct (i.e., the failure to inform the patient) and the harmful fact, should have ascertained, according to a reasoning based on logical and scientific probability, what choice the patient would have made had he been properly informed of the available and feasible treatment options in his particular case. Tonkin MA, Burke FD, Varian JP. Dupuytren’s contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients. J Hand Surg Br. 1984;9:156 − 62.
Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhum Ed Fr. 1993;60:808–13.
Huisstede BMA, Hoogvliet P, Coert JH, Fridén J, European HANDGUIDE Group. Dupuytren disease: European hand surgeons, hand therapists, and physical medicine and rehabilitation physicians agree on a multidisciplinary treatment guideline: results from the HANDGUIDE study. Plast Reconstr Surg. 2013;132:e964–76. https://doi.org/10.1097/01.prs.0000434410.40217.23
Beaudreuil J, Lermusiaux JL, Teyssedou JP, Lahalle S, Lasbleiz S, Bernabé B, et al. Multi-needle aponeurotomy for advanced Dupuytren’s disease: preliminary results of safety and efficacy (MNA 1 study). Joint Bone Spine. 2011;78:625–8. https://doi.org/10.1016/j.jbspin.2011.01.008
Basile G, Accetta R, Marinelli S, D’Ambrosi R, Petrucci QA, Giorgetti A, et al. Traumatology: adoption of the Sm@rtEven application for the remote evaluation of patients and possible medico-legal implications. J Clin Med. 2022;11:3644. https://doi.org/10.3390/jcm11133644
Amadei F, Bruno MC. Orthoplastic surgery: the modern vision of reconstructive surgery in orthopedics. Clin Ter. 2023;174:249–50. https://doi.org/10.7417/CT.2023.2529
Felici N, Marcoccio I, Giunta R, Haerle M, Leclercq C, Pajardi G, et al. Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence. Handchir Mikrochir Plast Chir. 2014;46:350–4. https://doi.org/10.1055/s-0034-1394420
Leibovic SJ. Normal and pathologic anatomy of Dupuytren disease. Hand Clin. 2018;34:315–29. https://doi.org/10.1016/j.hcl.2018.04.001
von Campe A, Mende K, Omaren H, Meuli-Simmen C. Painful nodules and cords in Dupuytren disease. J Hand Surg Am. 2012;37(7):1313-8. https://doi.org/10.1016/j.jhsa.2012.03.014. Epub 2012 May 4. PMID: 22560560.
Tubiana R. Evaluation of deformities in Dupuytren’s disease. Ann Chir Main. 1986;5(1):5–11. English, French. https://doi.org/10.1016/s0753-9053(86)80043-6. PMID: 3963905.
Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28:427–31. 10.1016/s0266-7681(03)00013 – 5.
Van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129:469–77. https://doi.org/10.1097/PRS.0b013e31823aea95
Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg Am. 2012;37:651–6. https://doi.org/10.1016/j.jhsa.2012.01.029
Pereira A, Massada M, Sousa R. Percutaneous needle fasciotomy in Dupuytren’s contracture: is it a viable technique. Acta Orthop Belg. 2012;78:30–4.
Zhou C, Selles RW, Slijper HP, Feitz R, van Kooij Y, Moojen TM, et al. Comparative effectiveness of percutaneous needle aponeurotomy and limited fasciectomy for Dupuytren’s contracture: a multicenter observational study. Plast Reconstr Surg. 2016;138:837–46. https://doi.org/10.1097/PRS.0000000000002560
Pelissier P, Gardet H, Pinsolle V. The palmar intermetacarpal flap in Dupuytren’s contracture. J Hand Surg Eur Vol. 2007 Feb;32(1):113. https://doi.org/10.1016/j.jhsb.2006.09.015
Degreef I, Voorde KV, Nuffel MV. Microfasciectomy in Dupuytren’s disease: microsurgery in the evolution toward safer and more efficient fasciectomy and hand surgery. EFORT Open Rev. 2023;8(5):291–7. https://doi.org/10.1530/EOR-23-0033. PMID: 37158415; PMCID: PMC10233807.
Högemann A, Wolfhard U, Kendoff D, Board TN, Olivier LC. Results of total aponeurectomy for Dupuytren’s contracture in 61 patients: a retrospective clinical study. Arch Orthop Trauma Surg. 2009;129:195–201. https://doi.org/10.1007/s00402-008-0657-z
Swartz WM, Lalonde DH, MOC-PS(SM). CME article: Dupuytren’s disease. Plast Reconstr Surg. 2008;121:1–10. https://doi.org/10.1097/01.prs.0000305932.46121.84
Denkler KA, Park KM, Alser O. Treatment options for Dupuytren’s disease: tips and tricks. Plast Reconstr Surg Glob Open. 2022;10:e4046. https://doi.org/10.1097/GOX.0000000000004046
Tanagho A, Beaumont J, Thomas R. A simple dressing technique following dermofasciectomy and full thickness skin grafting of the fingers in the treatment of severe Dupuytren’s contracture. J Hand Microsurg. 2015;7:317–9. https://doi.org/10.1007/s12593-015-0208-0
Peimer CA, Wilbrand S, Gerber RA, Chapman D, Szczypa PP. Safety and tolerability of collagenase clostridium histolyticum and fasciectomy for Dupuytren’s contracture. J Hand Surg Eur Vol. 2015;40:141–9. https://doi.org/10.1177/1753193414528843
Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Lindau T. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-Year Data. J Hand Surg Am. 2015;40:1597–605. https://doi.org/10.1016/j.jhsa.2015.04.036
Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am. 2010;35:2027–38.
Sandler AB, Scanaliato JP, Dennis T, Gonzalez Trevizo GA, Raiciulescu S, Nesti L, Dunn JC. Treatment of Dupuytren’s contracture with collagenase: a systematic review. Hand (N Y). 2022;17:815–24. https://doi.org/10.1177/1558944720974119
Nanchahal J, Chan JK. Treatments for early-stage Dupuytren’s disease: an evidence-based approach. J Hand Surg Eur Vol. 2023;48:191–8. https://doi.org/10.1177/17531934221131373
Ball C, Izadi D, Verjee LS, Chan J, Nanchahal J. Systematic review of non-surgical treatments for early dupuytren’s disease. BMC Musculoskelet Disord. 2016;17:345. https://doi.org/10.1186/s12891-016-1200-y
Nanchahal J, Ball C, Davidson D, Williams L, Sones W, McCann FE, et al. Anti-tumour necrosis factor therapy for Dupuytren’s disease: a randomised dose response proof of concept phase 2a clinical trial. EBioMedicine. 2018;33:282–8. https://doi.org/10.1016/j.ebiom.2018.06.022
National Institute for Health and Care Excellence. 2016. (accessed 11th February 2024).
Kemler MA, de Wijn RS, van Rijssen AL, van Kooij YE, Ottenhof MPM, van Heijl M, et al. Dutch multidisciplinary guideline on Dupuytren disease. J Hand Surg Glob Online. 2022;5(2):178–83. https://doi.org/10.1016/j.jhsg.2022.11
Knobloch K, Hellweg M, Sorg H, Nedelka T. Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren’s disease-a randomized controlled trial (DupuyShock). Lasers Med Sci. 2022;37:323–33. https://doi.org/10.1007/s10103-021-03254-9
Knobloch K, Vogt PM. High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (ledderhose’s disease). BMC Res Notes. 2012;5:542. https://doi.org/10.1186/1756-0500-5-542
Amadei F, Delle Femmine P, Basile G, Leigheb M. A modified adipofascial propeller flap for the dorsal fingertip. Minerva Orthop. 2023;74:329–32. https://doi.org/10.23736/S2784-8469.23.04316-X
Basile G. The autobiographical narrative as a damage assessment means injuries to profound subjective sensitivities – personalization and objectivization of medicolegal relevance. Clin Ter. 2022;173:585–9. https://doi.org/10.7417/CT.2022.2486
Finnikin SJ, Collins A. Consent is the conclusion of a decision making process. BMJ. 2022;378:o2200. https://doi.org/10.1136/bmj.o2200
Montanari Vergallo G, Zaami S. Guidelines and best practices: remarks on the Gelli-Bianco law. Clin Ter. 2018;169:e82–85. https://doi.org/10.7417/CT.2018.2059
Bielecki M, Wysocki M. Rola Rehabilitacji Po operacyjnym leczeniu choroby dupuytrena [The importance of rehabilitation after operative treatment of Dupuytren’s disease]. Wiad Lek. 2011;64:26–30.
Mullins PA. Postsurgical rehabilitation of Dupuytren’s disease. Hand Clin. 1999;15:167–74.
Winberg M, Turesson C. Patients’ perspectives of collagenase injection or needle fasciotomy and rehabilitation for Dupuytren disease, including hand function and occupational performance. Disabil Rehabil. 2023;45:986–96. https://doi.org/10.1080/09638288.2022.2046188
Fitzpatrick AV, Moltaji S, Ramji M, Martin S. Systematic review comparing cost analyses of fasciectomy, needle aponeurotomy, and collagenase injection for treatment of Dupuytren’s contracture: une analyse de coûts systématique comparant la fasciectomie, l’aponévrotomie percutanée à L’aiguille et l’injection de collagénase pou traiter la maladie de Dupuytren. Plast Surg (Oakv). 2021;29:257–64. https://doi.org/10.1177/2292550320963111
Chen NC, Shauver MJ, Chung KC. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg Am. 2011;36:e182632–1834. e32.
Zhang D, Earp BE, Blazar P. Collagenase treatment versus needle fasciotomy for single-digit Dupuytren contractures: a meta-analysis of randomized controlled trials. J Hand Surg Am. 2023;48(12):1200–9. Epub 2023 Sep 16. PMID: 37725027.
